tradingkey.logo
tradingkey.logo
Search

KraneShares MSCI All China Health Care Index ETF

KURE
Add to Watchlist
17.810USD
-0.300-1.66%
Close 11-16 16:00(ET)
200.00Volume
3.59KTurnover

KraneShares MSCI All China Health Care Index ETF

17.810
-0.300-1.66%

Today

-1.66%

5 Days

-5.77%

1 Month

+0.91%

6 Months

+9.06%

Year to Date

+4.52%

1 Year

-6.08%

Key Figures

17.970Open
18.110Prev. Close
18.229High
17.920Low
200.00Volume
3.59KTurnover
0.01Volume Ratio
18.98252wk High
14.38052wk Low
69.32KAvg Volume
3.95%Div Yield
0.715Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
17.820NAV
USDNAV Currency
3.46P/B
24.94Price to earnings ratio

KraneShares MSCI All China Health Care Index ETF Profile

Ticker SymbolKURE
Asset ClassEquity
Fund ManagerKraneShares
DomicileUS
Expense Ratio0.65%
Founded at2018-02-01
Tracking IndexMSCI China All Shares Health Care 10/40 Index
KURE was created on 2018-02-01 by KraneShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 115.48m in AUM and 43 holdings. KURE tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector.

Top 10 Holdings

No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
BeOne Medicines Ltd Ordinary Shares
BEIGF
--
0.000
--
366.52K
9.69%
$10.50M
Innovent Biologics Inc
1801.HK
--
0.000
--
816.00K
7.84%
$8.50M
WuXi Biologics (Cayman) Inc
2269.HK
--
0.000
--
1.34M
7.17%
$7.77M
4
Wuxi AppTec Co Ltd Class A
603259.SS
--
0.000
--
277.12K
5.41%
$5.87M
5
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
300760.SZ
--
0.000
--
216.25K
5.11%
$5.54M
6
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A
600276.SS
--
0.000
--
755.51K
4.80%
$5.21M
7
Akeso Inc Ordinary Shares
9926.HK
--
0.000
--
401.00K
3.96%
$4.29M
8
Sino Biopharmaceutical Ltd
1177.HK
--
0.000
--
6.13M
3.59%
$3.89M
9
CSPC Pharmaceutical Group Ltd
1093.HK
--
0.000
--
3.51M
3.46%
$3.75M
10
Wuxi AppTec Co Ltd
2359.HK
--
0.000
--
146.28K
3.17%
$3.44M
1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell

KraneShares MSCI All China Health Care Index ETF News

More news coming soon, stay tuned...

FAQs

What is the current price of KraneShares MSCI All China Health Care Index ETF (KURE)?

The current price of KraneShares MSCI All China Health Care Index ETF (KURE) is 18.11. Market data may be delayed; please refer to the timestamp displayed on the page.

What is the 52-week high of KraneShares MSCI All China Health Care Index ETF?

The 52-week high of KraneShares MSCI All China Health Care Index ETF is 18.98. Please refer to the page timestamp for the latest data.

What is the 52-week low of KraneShares MSCI All China Health Care Index ETF?

The 52-week low of KraneShares MSCI All China Health Care Index ETF is 14.38. Please refer to the page timestamp for the latest data.

What is the NAV of KraneShares MSCI All China Health Care Index ETF?

The NAV of KraneShares MSCI All China Health Care Index ETF is 17.82 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.

How is KraneShares MSCI All China Health Care Index ETF (KURE) performing?

The trading turnover of KraneShares MSCI All China Health Care Index ETF (KURE) is 9.04K. Its price changed by 2.61% over the past month, while its one-year return is -4.50%. View the KraneShares MSCI All China Health Care Index ETF price chart for more details.

Is KraneShares MSCI All China Health Care Index ETF (KURE) a safe investment?

No investment is completely risk-free. The risk level of KraneShares MSCI All China Health Care Index ETF (KURE) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.